Gene polymorphism of epidermal growth factor receptor and airway hyperresponsiveness in young allergic subjects without respiratory symptoms

Medical Science Monitor

Volumn 16, Issue 4, 2010, Pages

  Yoshikawa, Takahiro ^a   Kanazawa, Hiroshi ^a   Tanaka, Junji ^b   Fujimoto, Shigeo ^a   Yamamoto, Takushi ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Komejun Corporation   (Japan)

^c SHIMADZU CORPORATION   (Japan)

Author keywords

Asymptomatic airway hyperresponsiveness (Asymptomatic AHR); Epidermal growth factor receptor (EGFR); Haplotype block; Single nucleotide polymorphisms (SNPs); Young atopic adults

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; IMMUNOGLOBULIN E; METHACHOLINE; METHACHOLINE CHLORIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; INHALATION TEST; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ALLELE; BIOLOGICAL MODEL; BRONCHUS HYPERREACTIVITY; GENETIC POLYMORPHISM; GENETICS; HYPERSENSITIVITY; INTRON; PATHOLOGY; RISK;

ADOLESCENT; ADULT; ALLELES; BRONCHIAL HYPERREACTIVITY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; HYPERSENSITIVITY; INTRONS; MALE; METHACHOLINE CHLORIDE; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 77954262090     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Weiss ST, Raby BA, Rogers A: Asthma genetics and genomics 2009. Curr Opin Genet Dev, 2009; 19: 279-82
2. Albuquerque RV, Hayden CM, Palmer LJ et al: Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy, 1998; 28: 578-84
3. Burchard EG, Silverman EK, Rosenwasser LJ et al: Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med, 1999; 160: 919-22
4. Van Eerdewegh P, Little RD, Dupuis J et al: Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature, 2002; 418: 426-30
5. Drazen JM, Weiss ST: Genetics: inherit the wheeze. Nature, 2002; 418: 383-84
6. Raby BA, Silverman EK, Kwiatkowski DJ et al: ADAM33 polymorphisms and phenotype associations in childhood asthma. J Allergy Clin Immunol, 2004; 113: 1071-78
7. Hizawa N, Yamaguchi E, Jinushi E, Kawakami Y: A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population. Am J Respir Crit Care Med, 2000; 161: 906-9
8. Hizawa N, Maeda Y, Konno S et al: Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility. Clin Exp Allergy, 2006; 36: 872-76
9. Fryer AA, Bianco A, Hepple M et al: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med, 2000; 161: 1437-42
10. Tamer L, Calikoǧlu M, Ates NA et al: Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology, 2004; 9: 493-98
11. Moffatt MF, Kabesch M, Liang L et al: Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature, 2007; 448: 470-73
12. National Institute of Health: Global Initiative for Asthma (GINA)-Global strategy for asthma management and prevention. Update 2007
13. Ulrik CS, Backer V: Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J, 1999; 14: 892-96
14. Ulrik CS: Outcome of asthma: longitudinal changes in lung function. Eur Respir J, 1999; 13: 904-18
15. Vonk JM, Jongepier H, Panhuysen CI et al: Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax, 2003; 58: 322-27
16. Walter R, Gottlieb DJ, O'Connor GT: Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ Health Perspect, 2000; 108(S4): 733-42
17. Cockcroft DW, Marciniuk DD, Hurst TS et al: Methacholine challenge: test-shortening procedures. Chest, 2001; 120: 1857-60
18. Boulet LP: Physiopathology of airway hyperresponsiveness. Curr Allergy Asthma Rep, 2003; 3: 166-71
19. Wardlaw AJ, Brightling CE, Green R et al: New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond), 2002; 103: 201-11
20. Jansen DF, Timens W, Kraan J et al: (A) symptomatic bronchial hyperresponsiveness and asthma. Respir Med, 1997; 91: 121-34
21. Trigg CJ, Bennett JB, Tooley M et al: A general practice based survey of bronchial hyperresponsiveness and its relation to symptoms, sex, age, atopy, and smoking. Thorax, 1990; 45: 866-72
22. Burney PG, Britton JR, Chinn S et al: Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax, 1987; 42: 38-44
23. Hopp RJ, Townley RG, Biven RE et al: The presence of airway reactivity before the development of asthma. Am Rev Respir Dis, 1990; 141: 2-8
24. Zhong NS, Chen RC, Yang MO et al: Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma? A two-year follow-up of young students with bronchial hyperresponsiveness. Chest, 1992; 102: 1104-9
25. Brutsche MH, Downs SH, Schindler C et al: Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax, 2006; 61: 671-77
26. Nomura N, Yoshikawa T, Kamoi H et al: Induced sputum analysis in asymptomatic young adults with bronchial hyperresponsiveness to methacholine. Respirology, 2007; 12: 516-22
27. Laprise C, Laviolette M, Boutet M, Boulet LP: Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J, 1999; 14: 63-73
28. Burgel PR, Nadel JA: Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax, 2004; 59: 992-96
29. Ingram JL, Bonner JC: EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. Curr Mol Med, 2006; 6: 409-21
30. Boxall C, Holgate ST, Davies DE: The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J, 2006; 27: 208-29
31. Puddicombe SM, Polosa R, Richter A et al: Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J, 2000; 14: 1362-74
32. Lordan JL, Bucchieri F, Richter A et al: Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol, 2002; 169: 407-14
33. Tamaoka M, Hassan M, McGovern T et al: The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J, 2008; 32: 1213-23
34. Hur GY, Lee SY, Lee SH et al: Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med, 2007; 39: 367-75
35. Crapo RO, Casaburi R, Coates AL et al: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med, 2000; 161: 309-29
36. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ, 2001; 79: 373-74
37. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc, 1977; 39: 1-38
38. Hill WG: Estimation of linkage disequilibrium in randomly mating populations. Heredity, 1974; 33: 229-39
39. Weir BS: Genetic data analysis. Methods for discrete population genetic data. Sinauer, Sunderland, MA, 1990
40. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in diploid population. Mol Biol Evol, 1995; 12: 921-27
41. Wall JD, Pritchard JK: Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet, 2003; 4: 587-97
42. Shindo H, Chigira H, Tanaka J et al: Grouping preprocess to accurately extend application of EM algorithm to haplotype inference. J Hum Genet, 2008; 53: 747-56
43. Wenzel SE: Asthma: defining of the persistent adult phenotypes. Lancet, 2006; 368: 804-13
44. London SJ, James Gauderman W, Avol E et al: Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma Epidemiology, 2001; 12: 577-83
45. Duffy DL: Genetic epidemiology of asthma. Epidemiol Rev, 1997; 19: 129-43
46. Cogswell JJ: Influence of maternal atopy on atopy in the offspring. Clin Exp Allergy, 2000; 30: 1-3
47. Litonjua AA, Carey VJ, Burge HA et al: Parental history and the risk for childhood asthma. Does mother confer more risk than father? Am J Respir Crit Care Med, 1998; 158: 176-81
48. ten Brinke A, Zwinderman AH, Sterk PJ et al: Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med, 2001; 164: 744-48
49. Ulrik CS, Backer V, Dirksen A: Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma, 1992; 29: 29-38
50. Ulrik CS, Backer V, Dirksen A: A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax, 1992; 47: 14-18
51. Strachan DP, Butland BK, Anderson HR: Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ, 1996; 312: 1195-99
52. Strachan DP, Griffiths JM, Johnston ID, Anderson HR: Ventilatory function in British adults after asthma or wheezing illness at ages 0-35. Am J Respir Crit Care Med, 1996; 154: 1629-35
53. Kiley J, Smith R, Noel P: Asthma phenotypes. Curr Opin Pulm Med, 2007; 13: 19-23
54. Hargreave FE, Ryan G, Thomson NC et al: Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol, 1981; 68: 347-55
55. Platts-Mills TA: Mechanisms of bronchial reactivity: the role of immunoglobulin E. Am Rev Respir Dis, 1992; 145: S44-47
56. Soriano JB, Tobías A, Kogevinas M et al: Atopy and nonspecific bronchial responsiveness. A population-based assessment. Spanish Group of the European Community Respiratory Health Survey. Am J Respir Crit Care Med, 1996; 154: 1636-40
57. Hargreave FE, Dolovich J, O'Byrne PM et al: The origin of airway hyperresponsiveness. J Allergy Clin Immunol, 1986; 78: 825-32
58. Cockcroft DW, Davis BE: Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol, 2006; 118: 551-59
59. Altounyan RE: Variation of drug action on airway obstruction in man. Thorax, 1964; 19: 406-15
60. Boulet LP, Cartier A, Thomson NC et al: Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol, 1983; 71: 399-406
61. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE: Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy, 1977; 7: 503-13
62. Speight AN, Lee DA, Hey EN: Underdiagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed), 1983; 286: 1253-56
63. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP: Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol, 1992; 89: 23-30
64. Bousquet J, Jeffery PK, Busse WW et al: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med, 2000; 161: 1720-45
65. Leigh R, Ellis R, Wattie J et al: Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol, 2002; 27: 526-35
66. Homer RJ, Elias JA: Consequences of long-term inflammation. Airway remodeling. Clin Chest Med, 2000; 21: 331-43, ix
67. Homer RJ, Elias JA: Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda), 2005; 20: 28-35
68. Malo JL, Pineau L, Cartier A, Martin RR: Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis, 1983; 128: 8-11
69. Braman SS, Barrows AA, DeCotiis BA et al: Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest, 1987; 91: 671-74
70. Crockcroft DW, Murdock KY, Berscheid BA: Relationship between atopy and bronchial responsiveness to histamine in a random population. Ann Allergy, 1984; 53: 26-29
71. Boulet LP: Asymptomatic airway hyperresponsiveness: a curiosity or an opportunity to prevent asthma? Am J Respir Crit Care Med, 2003; 167: 371-78
72. Tantisira KG, Colvin R, Tonascia J et al, Childhood Asthma Management Program Research Group: Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med, 2008; 178: 325-31
73. Goksör E, Amark M, Alm B et al: Asthma symptoms in early childhood - what happens then? Acta Paediatr, 2006; 95: 471-78
74. Wang X, Saito J, Ishida T, Munakata M: Polymorphism of EGFR intron 1 is associated with susceptibility and severity of asthma. J Asthma, 2006; 43: 711-15
75. Gray L, Peat JK, Belousova E et al: Family patterns of asthma, atopy and airway hyperresponsiveness: an epidemiological study. Clin Exp Allergy, 2000; 30: 393-99